Neurocrine Biosciences Market Cap

Neurocrine Biosciences has a market cap or net worth of $13.03 billion as of March 9, 2026. Its market cap has increased by 12.57% in one year.

Market Cap

13.03B

Enterprise Value

11.98B

1-Year Change

12.57%

Ranking

#795

Market Cap Chart

Since December 1, 1998, Neurocrine Biosciences's market cap has increased from $124.10M to $13.03B, an increase of 10,401.37%. That is a compound annual growth rate of 18.60%.

Market Cap History

Date	Market Cap	% Change
Mar 6, 2026	12.86B	-9.06%
Dec 31, 2025	14.14B	2.32%
Dec 31, 2024	13.82B	6.76%
Dec 29, 2023	12.95B	12.74%
Dec 30, 2022	11.48B	42.11%
Dec 31, 2021	8.08B	-9.78%
Dec 31, 2020	8.96B	-9.54%
Dec 31, 2019	9.90B	52.87%
Dec 31, 2018	6.48B	-5.69%
Dec 29, 2017	6.87B	104.24%
Dec 30, 2016	3.36B	-31.05%
Dec 31, 2015	4.88B	187.17%
Dec 31, 2014	1.70B	169.95%
Dec 31, 2013	629.00M	26.66%
Dec 31, 2012	496.60M	5.73%
Dec 30, 2011	469.70M	12.07%
Dec 31, 2010	419.10M	293.15%
Dec 31, 2009	106.60M	-13.68%
Dec 31, 2008	123.50M	-28.41%
Dec 31, 2007	172.50M	-56.31%
Dec 29, 2006	394.80M	-82.96%
Dec 30, 2005	2.32B	28.86%
Dec 31, 2004	1.80B	-6.54%
Dec 31, 2003	1.92B	37.67%
Dec 31, 2002	1.40B	3.88%

View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Haleon	44.97B
Teva Pharmaceutical Industries	36.16B
United Therapeutics	20.96B
Viatris	16.30B
Dr. Reddy's Laboratories	11.81B
Elanco Animal Health	11.61B
Regencell Bioscience Holdings	11.55B
Alkermes	4.77B

Market Cap Rankings